| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.698 | 0.004 | 0.776 | Psychostimulant | 0.588 0.006 CID_3085253 0.776 0.004 CID_154699655 | CID_154699655 | |
| 0.623 | 0.012 | 0.623 | 5 Hydroxytryptamine release stimulant | 0.617 0.013 CID_3085253 0.513 0.025 CID_154699655 | ||
| 0.623 | 0.016 | 0.711 | Aldehyde oxidase inhibitor | 0.686 0.009 CID_3085253 0.711 0.008 CID_154699655 | CID_154699655 | |
| 0.534 | 0.004 | 0.534 | Alpha 2b adrenoreceptor antagonist | 0.329 0.007 CID_3085253 0.414 0.005 CID_154699655 | ||
| 0.523 | 0.004 | 0.523 | 5 Hydroxytryptamine 2C antagonist | 0.369 0.006 CID_3085253 0.298 0.009 CID_154699655 | ||
| 0.505 | 0.005 | 0.505 | Nav1.2 sodium channel blocker | 0.469 0.005 CID_3085253 0.37 0.009 CID_154699655 | ||
| 0.496 | 0.006 | 0.496 | 5 Hydroxytryptamine 2 antagonist | 0.322 0.015 CID_3085253 0.369 0.011 CID_154699655 | ||
| 0.5 | 0.012 | 0.542 | Anticonvulsant | 0.542 0.01 CID_3085253 0.246 0.059 CID_154699655 | CID_3085253 | |
| 0.507 | 0.025 | 0.507 | Calcium channel L-type activator | 0.495 0.03 CID_154699655 | ||
| 0.481 | 0.008 | 0.481 | 5 Hydroxytryptamine antagonist | 0.314 0.017 CID_3085253 0.357 0.014 CID_154699655 | ||
| 0.496 | 0.027 | 0.522 | GABA C receptor rho-3 antagonist | 0.522 0.02 CID_3085253 0.499 0.026 CID_154699655 | CID_3085253 | |
| 0.479 | 0.012 | 0.551 | Sigma receptor agonist | 0.432 0.017 CID_3085253 0.551 0.006 CID_154699655 | CID_154699655 | |
| 0.472 | 0.004 | 0.472 | Nav1.3 sodium channel blocker | 0.313 0.008 CID_3085253 0.34 0.006 CID_154699655 | ||
| 0.467 | 0.028 | 0.467 | Spasmolytic | 0.35 0.052 CID_3085253 0.437 0.033 CID_154699655 | ||
| 0.442 | 0.007 | 0.442 | 5 Hydroxytryptamine 2B antagonist | 0.36 0.01 CID_3085253 0.308 0.014 CID_154699655 | ||
| 0.42 | 0.009 | 0.42 | Alpha adrenoreceptor antagonist | 0.239 0.022 CID_3085253 0.383 0.01 CID_154699655 | ||
| 0.408 | 0.007 | 0.408 | 5 Hydroxytryptamine 2A antagonist | 0.256 0.014 CID_3085253 0.275 0.013 CID_154699655 | ||
| 0.397 | 0.003 | 0.397 | 5 Hydroxytryptamine 5A antagonist | 0.265 0.004 CID_3085253 0.245 0.004 CID_154699655 | ||
| 0.394 | 0.005 | 0.394 | Histamine H1 receptor antagonist | 0.276 0.008 CID_3085253 0.22 0.012 CID_154699655 | ||
| 0.372 | 0.003 | 0.372 | 5 Hydroxytryptamine 5 antagonist | 0.245 0.004 CID_3085253 0.229 0.004 CID_154699655 | ||
| 0.374 | 0.006 | 0.374 | 5 Hydroxytryptamine 1E antagonist | 0.323 0.018 CID_3085253 0.346 0.011 CID_154699655 | ||
| 0.437 | 0.07 | 0.437 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.347 0.154 CID_3085253 0.29 0.226 CID_154699655 | ||
| 0.373 | 0.008 | 0.373 | Alpha 1 adrenoreceptor antagonist | 0.209 0.019 CID_3085253 0.325 0.009 CID_154699655 | ||
| 0.433 | 0.071 | 0.433 | Analgesic | 0.232 0.201 CID_3085253 0.309 0.135 CID_154699655 | ||
| 0.446 | 0.085 | 0.488 | Caspase 9 stimulant | 0.488 0.065 CID_3085253 0.484 0.066 CID_154699655 | CID_3085253 | |
| 0.365 | 0.005 | 0.365 | Alpha 2a adrenoreceptor antagonist | 0.231 0.011 CID_3085253 0.269 0.008 CID_154699655 | ||
| 0.362 | 0.007 | 0.362 | Alpha 1a adrenoreceptor antagonist | 0.187 0.018 CID_3085253 0.31 0.009 CID_154699655 | ||
| 0.353 | 0.005 | 0.353 | 5 Hydroxytryptamine uptake inhibitor | 0.112 0.023 CID_3085253 0.193 0.012 CID_154699655 | ||
| 0.353 | 0.006 | 0.353 | Alpha 1b adrenoreceptor antagonist | 0.197 0.015 CID_3085253 0.308 0.007 CID_154699655 | ||
| 0.341 | 0.005 | 0.341 | Alpha 2c adrenoreceptor antagonist | 0.215 0.015 CID_3085253 0.253 0.01 CID_154699655 | ||
| 0.367 | 0.039 | 0.367 | Calcium channel activator | 0.319 0.073 CID_3085253 0.308 0.084 CID_154699655 | ||
| 0.326 | 0.003 | 0.326 | Sphingomyelinase inhibitor | 0.243 0.005 CID_3085253 0.293 0.004 CID_154699655 | ||
| 0.318 | 0.006 | 0.318 | Dopamine D4 antagonist | 0.235 0.01 CID_3085253 0.299 0.007 CID_154699655 | ||
| 0.319 | 0.009 | 0.319 | Antihistaminic | 0.18 0.024 CID_3085253 0.133 0.038 CID_154699655 | ||
| 0.314 | 0.009 | 0.314 | Histamine antagonist | 0.171 0.024 CID_3085253 0.115 0.04 CID_154699655 | ||
| 0.306 | 0.005 | 0.306 | Alpha 1d adrenoreceptor antagonist | 0.167 0.012 CID_3085253 0.249 0.007 CID_154699655 | ||
| 0.299 | 0.003 | 0.376 | Histamine N-methyltransferase inhibitor | 0.376 0.003 CID_3085253 0.21 0.005 CID_154699655 | CID_3085253 | |
| 0.336 | 0.042 | 0.404 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.404 0.02 CID_3085253 0.298 0.066 CID_154699655 | CID_3085253 | |
| 0.288 | 0.012 | 0.339 | Dopamine antagonist | 0.181 0.021 CID_3085253 0.339 0.01 CID_154699655 | CID_154699655 | |
| 0.277 | 0.005 | 0.277 | Adrenaline uptake inhibitor | 0.095 0.02 CID_3085253 0.176 0.007 CID_154699655 | ||
| 0.279 | 0.01 | 0.279 | Nav1.1 sodium channel blocker | 0.234 0.014 CID_3085253 0.233 0.014 CID_154699655 | ||
| 0.275 | 0.009 | 0.275 | Alpha 2 adrenoreceptor antagonist | 0.17 0.023 CID_3085253 0.191 0.019 CID_154699655 | ||
| 0.272 | 0.007 | 0.416 | Dopamine D1 antagonist | 0.182 0.012 CID_3085253 0.416 0.004 CID_154699655 | CID_154699655 | |
| 0.279 | 0.018 | 0.279 | Acetylcholine M1 receptor antagonist | 0.279 0.019 CID_3085253 0.223 0.033 CID_154699655 | ||
| 0.293 | 0.034 | 0.309 | MAP-kinase-activated kinase 5 inhibitor | 0.302 0.029 CID_3085253 0.309 0.025 CID_154699655 | CID_154699655 | |
| 0.326 | 0.069 | 0.326 | Vasodilator, coronary | 0.277 0.108 CID_3085253 0.297 0.09 CID_154699655 | ||
| 0.267 | 0.01 | 0.267 | ATPase inhibitor | 0.188 0.049 CID_3085253 0.257 0.012 CID_154699655 | ||
| 0.264 | 0.008 | 0.264 | Nav1.6 sodium channel blocker | 0.247 0.01 CID_3085253 0.198 0.02 CID_154699655 | ||
| 0.26 | 0.012 | 0.26 | 5 Hydroxytryptamine 1 antagonist | 0.141 0.025 CID_3085253 0.225 0.014 CID_154699655 | ||
| 0.247 | 0.004 | 0.264 | NMDA 2A receptor antagonist | 0.264 0.004 CID_3085253 0.262 0.004 CID_154699655 | CID_3085253 | |
| 0.258 | 0.018 | 0.258 | Anesthetic local | 0.162 0.044 CID_3085253 0.188 0.035 CID_154699655 | ||
| 0.251 | 0.015 | 0.251 | Butyrylcholinesterase inhibitor | 0.2 0.021 CID_3085253 0.207 0.02 CID_154699655 | ||
| 0.33 | 0.097 | 0.33 | Calpain 2 inhibitor | 0.271 0.135 CID_3085253 0.213 0.176 CID_154699655 | ||
| 0.28 | 0.048 | 0.28 | Gastrin inhibitor | 0.228 0.108 CID_3085253 0.223 0.115 CID_154699655 | ||
| 0.245 | 0.018 | 0.245 | 5 Hydroxytryptamine 3E antagonist | 0.229 0.029 CID_3085253 0.188 0.085 CID_154699655 | ||
| 0.234 | 0.009 | 0.248 | Protein kinase C gamma inhibitor | 0.248 0.007 CID_3085253 0.201 0.014 CID_154699655 | CID_3085253 | |
| 0.233 | 0.01 | 0.251 | Neuropeptide Y1 antagonist | 0.251 0.008 CID_3085253 0.197 0.02 CID_154699655 | CID_3085253 | |
| 0.251 | 0.031 | 0.319 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.319 0.015 CID_3085253 0.142 0.069 CID_154699655 | CID_3085253 | |
| 0.225 | 0.009 | 0.225 | Dopamine D3 antagonist | 0.116 0.021 CID_3085253 0.206 0.01 CID_154699655 | ||
| 0.245 | 0.03 | 0.245 | Cholinergic | 0.153 0.074 CID_3085253 0.219 0.039 CID_154699655 | ||
| 0.225 | 0.01 | 0.225 | 5 Hydroxytryptamine 7 antagonist | 0.224 0.01 CID_3085253 0.103 0.025 CID_154699655 | ||
| 0.242 | 0.027 | 0.242 | Antipruritic | 0.241 0.028 CID_3085253 0.239 0.028 CID_154699655 | ||
| 0.225 | 0.014 | 0.273 | Dopamine D2 antagonist | 0.159 0.021 CID_3085253 0.273 0.012 CID_154699655 | CID_154699655 | |
| 0.23 | 0.019 | 0.241 | Antiadrenergic | 0.164 0.032 CID_3085253 0.241 0.018 CID_154699655 | CID_154699655 | |
| 0.217 | 0.012 | 0.361 | NMDA receptor antagonist | 0.336 0.005 CID_3085253 0.361 0.005 CID_154699655 | CID_154699655 | |
| 0.213 | 0.008 | 0.213 | Alpha adrenoreceptor agonist | 0.152 0.016 CID_3085253 0.153 0.016 CID_154699655 | ||
| 0.228 | 0.026 | 0.228 | Acetylcholinesterase inhibitor | 0.154 0.053 CID_3085253 0.219 0.028 CID_154699655 | ||
| 0.222 | 0.02 | 0.234 | Adrenaline antagonist | 0.157 0.033 CID_3085253 0.234 0.018 CID_154699655 | CID_154699655 | |
| 0.21 | 0.01 | 0.21 | Adenylate cyclase stimulant | 0.206 0.011 CID_3085253 0.209 0.01 CID_154699655 | ||
| 0.213 | 0.014 | 0.213 | 5 Hydroxytryptamine 1A antagonist | 0.135 0.022 CID_3085253 0.207 0.014 CID_154699655 | ||
| 0.202 | 0.007 | 0.202 | Dopamine D4 agonist | 0.189 0.007 CID_3085253 0.108 0.013 CID_154699655 | ||
| 0.202 | 0.008 | 0.202 | 5 Hydroxytryptamine 1B antagonist | 0.116 0.018 CID_3085253 0.088 0.029 CID_154699655 | ||
| 0.205 | 0.012 | 0.205 | Interleukin 8 antagonist | 0.201 0.013 CID_3085253 0.186 0.017 CID_154699655 | ||
| 0.203 | 0.011 | 0.305 | Protein kinase C zeta inhibitor | 0.305 0.005 CID_3085253 0.224 0.009 CID_154699655 | CID_3085253 | |
| 0.2 | 0.007 | 0.2 | 5 Hydroxytryptamine 1D antagonist | 0.135 0.014 CID_3085253 0.084 0.029 CID_154699655 | ||
| 0.213 | 0.022 | 0.213 | GABA C receptor rho-2 antagonist | 0.171 0.05 CID_3085253 0.196 0.031 CID_154699655 | ||
| 0.266 | 0.078 | 0.266 | Ca(v)3.3 blocker | 0.233 0.128 CID_3085253 | ||
| 0.247 | 0.059 | 0.284 | Neuropeptide Y2 antagonist | 0.284 0.028 CID_3085253 0.198 0.123 CID_154699655 | CID_3085253 | |
| 0.243 | 0.056 | 0.257 | Peptidyltransferase inhibitor | 0.254 0.048 CID_3085253 0.257 0.046 CID_154699655 | CID_154699655 | |
| 0.19 | 0.004 | 0.19 | 5 Hydroxytryptamine 2 agonist | 0.186 0.004 CID_3085253 0.15 0.005 CID_154699655 | ||
| 0.25 | 0.064 | 0.285 | Cyclic AMP phosphodiesterase inhibitor | 0.285 0.048 CID_3085253 0.218 0.082 CID_154699655 | CID_3085253 | |
| 0.213 | 0.03 | 0.213 | Toll-Like receptor 9 antagonist | 0.118 0.088 CID_154699655 | ||
| 0.188 | 0.007 | 0.188 | Dopamine uptake inhibitor | 0.109 0.016 CID_3085253 0.096 0.019 CID_154699655 | ||
| 0.186 | 0.005 | 0.186 | Histamine H2 receptor antagonist | 0.119 0.021 CID_3085253 0.115 0.024 CID_154699655 | ||
| 0.188 | 0.011 | 0.188 | 5 Hydroxytryptamine 1F antagonist | 0.116 0.025 CID_3085253 0.103 0.03 CID_154699655 | ||
| 0.188 | 0.012 | 0.188 | Nitric-oxide synthase inhibitor | 0.187 0.012 CID_3085253 0.115 0.041 CID_154699655 | ||
| 0.206 | 0.033 | 0.254 | NADPH oxidase inhibitor | 0.254 0.02 CID_3085253 0.232 0.025 CID_154699655 | CID_3085253 | |
| 0.183 | 0.011 | 0.225 | Dopamine agonist | 0.162 0.014 CID_3085253 0.225 0.008 CID_154699655 | CID_154699655 | |
| 0.189 | 0.02 | 0.201 | MAP3K9 inhibitor | 0.201 0.015 CID_3085253 0.175 0.03 CID_154699655 | CID_3085253 | |
| 0.182 | 0.016 | 0.182 | 5 Hydroxytryptamine agonist | 0.177 0.017 CID_3085253 0.11 0.031 CID_154699655 | ||
| 0.177 | 0.012 | 0.282 | NMDA 2 receptor antagonist | 0.282 0.005 CID_3085253 0.173 0.012 CID_154699655 | CID_3085253 | |
| 0.194 | 0.032 | 0.194 | Calcium channel blocker | 0.145 0.063 CID_3085253 0.137 0.07 CID_154699655 | ||
| 0.238 | 0.077 | 0.25 | Antiamyloidogenic | 0.228 0.082 CID_3085253 0.25 0.071 CID_154699655 | CID_154699655 | |
| 0.182 | 0.021 | 0.237 | 5 Hydroxytryptamine 3A agonist | 0.237 0.007 CID_3085253 0.11 0.065 CID_154699655 | CID_3085253 | |
| 0.166 | 0.008 | 0.166 | Glutamate (mGluR7) agonist | 0.123 0.027 CID_3085253 0.111 0.041 CID_154699655 | ||
| 0.166 | 0.008 | 0.166 | Acetylcholine M4 receptor antagonist | 0.136 0.013 CID_3085253 0.092 0.035 CID_154699655 | ||
| 0.183 | 0.029 | 0.183 | Acetylcholine muscarinic antagonist | 0.158 0.039 CID_3085253 0.138 0.052 CID_154699655 | ||
| 0.198 | 0.045 | 0.258 | Diuretic | 0.258 0.029 CID_3085253 0.14 0.086 CID_154699655 | CID_3085253 | |
| 0.24 | 0.089 | 0.24 | Cardiotonic | 0.194 0.125 CID_3085253 0.199 0.12 CID_154699655 | ||
| 0.215 | 0.066 | 0.235 | Anesthetic general | 0.235 0.057 CID_3085253 0.17 0.094 CID_154699655 | CID_3085253 | |
| 0.279 | 0.135 | 0.37 | Histamine release inhibitor | 0.37 0.091 CID_3085253 0.339 0.105 CID_154699655 | CID_3085253 | |
| 0.237 | 0.095 | 0.313 | 5 Hydroxytryptamine uptake stimulant | 0.313 0.039 CID_3085253 0.214 0.127 CID_154699655 | CID_3085253 | |
| 0.209 | 0.068 | 0.244 | Neurotrophic factor enhancer | 0.205 0.072 CID_3085253 0.244 0.042 CID_154699655 | CID_154699655 | |
| 0.232 | 0.091 | 0.286 | DNA damaging | 0.286 0.063 CID_3085253 0.215 0.104 CID_154699655 | CID_3085253 | |
| 0.154 | 0.014 | 0.154 | Acetylcholine release stimulant | 0.125 0.041 CID_3085253 0.107 0.071 CID_154699655 | ||
| 0.148 | 0.01 | 0.148 | Alpha 1 adrenoreceptor agonist | 0.086 0.021 CID_3085253 0.082 0.022 CID_154699655 | ||
| 0.177 | 0.039 | 0.177 | Cholinergic antagonist | 0.148 0.053 CID_3085253 0.119 0.075 CID_154699655 | ||
| 0.161 | 0.024 | 0.203 | Mediator release inhibitor | 0.178 0.019 CID_3085253 0.203 0.014 CID_154699655 | CID_154699655 | |
| 0.207 | 0.071 | 0.286 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.286 0.04 CID_3085253 0.166 0.108 CID_154699655 | CID_3085253 | |
| 0.163 | 0.028 | 0.163 | Calcium channel (voltage-sensitive) blocker | 0.117 0.06 CID_3085253 0.113 0.065 CID_154699655 | ||
| 0.149 | 0.015 | 0.149 | Toll-Like receptor 3 antagonist | 0.116 0.032 CID_154699655 | ||
| 0.136 | 0.004 | 0.136 | 5 Hydroxytryptamine 4 antagonist | 0.132 0.004 CID_3085253 0.089 0.01 CID_154699655 | ||
| 0.152 | 0.021 | 0.198 | Neuropeptide Y antagonist | 0.198 0.015 CID_3085253 | CID_3085253 | |
| 0.169 | 0.041 | 0.169 | Acetylcholine antagonist | 0.143 0.054 CID_3085253 0.112 0.078 CID_154699655 | ||
| 0.138 | 0.011 | 0.144 | 5 Hydroxytryptamine 3 antagonist | 0.144 0.01 CID_3085253 0.062 0.034 CID_154699655 | CID_3085253 | |
| 0.202 | 0.074 | 0.312 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.312 0.04 CID_3085253 0.139 0.124 CID_154699655 | CID_3085253 | |
| 0.139 | 0.012 | 0.139 | Calcium channel L-type blocker | 0.1 0.025 CID_3085253 0.106 0.022 CID_154699655 | ||
| 0.134 | 0.008 | 0.134 | 5 Hydroxytryptamine 6 antagonist | 0.114 0.011 CID_3085253 0.06 0.036 CID_154699655 | ||
| 0.21 | 0.085 | 0.21 | HERG channel blocker | 0.167 0.113 CID_3085253 | ||
| 0.198 | 0.073 | 0.206 | Non-steroidal antiinflammatory agent | 0.206 0.066 CID_3085253 0.179 0.088 CID_154699655 | CID_3085253 | |
| 0.207 | 0.082 | 0.207 | ErbB-1 antagonist | 0.183 0.111 CID_3085253 0.185 0.108 CID_154699655 | ||
| 0.16 | 0.038 | 0.162 | Pregnane X receptor agonist | 0.162 0.035 CID_3085253 0.134 0.09 CID_154699655 | CID_3085253 | |
| 0.13 | 0.01 | 0.13 | Acetylcholine M5 receptor antagonist | 0.084 0.022 CID_3085253 0.086 0.022 CID_154699655 | ||
| 0.221 | 0.101 | 0.275 | Tyrosine 3 hydroxylase inhibitor | 0.275 0.048 CID_3085253 0.229 0.091 CID_154699655 | CID_3085253 | |
| 0.209 | 0.09 | 0.209 | Potassium channel (Voltage-sensitive) blocker | 0.15 0.137 CID_3085253 | ||
| 0.135 | 0.018 | 0.24 | CXC chemokine 4 receptor antagonist | 0.24 0.008 CID_3085253 0.072 0.035 CID_154699655 | CID_3085253 | |
| 0.136 | 0.018 | 0.175 | Lanosterol 14 alpha demethylase inhibitor | 0.175 0.006 CID_3085253 0.104 0.05 CID_154699655 | CID_3085253 | |
| 0.131 | 0.014 | 0.196 | CXC chemokine receptor antagonist | 0.196 0.005 CID_3085253 0.09 0.03 CID_154699655 | CID_3085253 | |
| 0.157 | 0.041 | 0.22 | Adenylate cyclase inhibitor | 0.22 0.023 CID_3085253 0.149 0.045 CID_154699655 | CID_3085253 | |
| 0.121 | 0.006 | 0.121 | Phospholipase D inhibitor | 0.091 0.021 CID_3085253 0.091 0.022 CID_154699655 | ||
| 0.119 | 0.004 | 0.119 | 5 Hydroxytryptamine 3B antagonist | 0.083 0.006 CID_3085253 0.05 0.014 CID_154699655 | ||
| 0.167 | 0.053 | 0.187 | MAO inhibitor | 0.177 0.049 CID_3085253 0.187 0.045 CID_154699655 | CID_154699655 | |
| 0.153 | 0.04 | 0.186 | MAO A inhibitor | 0.126 0.049 CID_3085253 0.186 0.032 CID_154699655 | CID_154699655 | |
| 0.13 | 0.017 | 0.13 | Bromodomain-containing protein 2 inhibitor | 0.109 0.031 CID_3085253 0.094 0.048 CID_154699655 | ||
| 0.123 | 0.011 | 0.127 | Protein kinase C eta inhibitor | 0.127 0.01 CID_3085253 0.104 0.016 CID_154699655 | CID_3085253 | |
| 0.147 | 0.038 | 0.147 | Falcipain 3 inhibitor | 0.11 0.061 CID_3085253 0.094 0.077 CID_154699655 | ||
| 0.114 | 0.005 | 0.127 | 5 Hydroxytryptamine 7 agonist | 0.127 0.005 CID_3085253 0.075 0.016 CID_154699655 | CID_3085253 | |
| 0.17 | 0.063 | 0.2 | Neurotensin receptor agonist | 0.2 0.035 CID_3085253 0.179 0.05 CID_154699655 | CID_3085253 | |
| 0.142 | 0.036 | 0.18 | Chemokine receptor antagonist | 0.18 0.022 CID_3085253 | CID_3085253 | |
| 0.135 | 0.029 | 0.191 | GABA C receptor rho-1 antagonist | 0.191 0.01 CID_3085253 0.112 0.048 CID_154699655 | CID_3085253 | |
| 0.113 | 0.011 | 0.139 | Beta 3 adrenoreceptor antagonist | 0.068 0.038 CID_3085253 0.139 0.007 CID_154699655 | CID_154699655 | |
| 0.105 | 0.004 | 0.105 | Adenylate cyclase 1 inhibitor | 0.104 0.004 CID_3085253 0.086 0.006 CID_154699655 | ||
| 0.109 | 0.01 | 0.109 | Protein kinase C beta inhibitor | 0.107 0.01 CID_3085253 0.088 0.021 CID_154699655 | ||
| 0.118 | 0.019 | 0.118 | Glycine receptor antagonist | 0.108 0.026 CID_3085253 0.097 0.035 CID_154699655 | ||
| 0.112 | 0.016 | 0.12 | Cannabinoid CB1 receptor agonist | 0.12 0.014 CID_3085253 0.062 0.041 CID_154699655 | CID_3085253 | |
| 0.108 | 0.012 | 0.108 | Alpha 2 adrenoreceptor agonist | 0.084 0.021 CID_3085253 0.074 0.028 CID_154699655 | ||
| 0.106 | 0.012 | 0.134 | 5 Hydroxytryptamine 2A agonist | 0.134 0.007 CID_3085253 0.084 0.024 CID_154699655 | CID_3085253 | |
| 0.22 | 0.129 | 0.236 | Insulysin inhibitor | 0.236 0.11 CID_3085253 | CID_3085253 | |
| 0.095 | 0.007 | 0.095 | Potassium channel small-conductance Ca-activated blocker | 0.062 0.016 CID_3085253 | ||
| 0.123 | 0.036 | 0.123 | Acetylcholine agonist | |||
| 0.136 | 0.049 | 0.136 | DNA intercalator | 0.124 0.055 CID_3085253 0.12 0.057 CID_154699655 | ||
| 0.093 | 0.005 | 0.1 | Histamine H4 receptor antagonist | 0.1 0.005 CID_3085253 0.045 0.041 CID_154699655 | CID_3085253 | |
| 0.114 | 0.027 | 0.12 | Glutamate release inhibitor | 0.12 0.022 CID_3085253 0.091 0.059 CID_154699655 | CID_3085253 | |
| 0.13 | 0.043 | 0.13 | Nav1.5 sodium channel blocker | 0.126 0.048 CID_3085253 | ||
| 0.089 | 0.003 | 0.089 | Histamine H1 receptor agonist | 0.076 0.004 CID_3085253 0.054 0.014 CID_154699655 | ||
| 0.214 | 0.129 | 0.222 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.222 0.111 CID_3085253 0.195 0.181 CID_154699655 | CID_3085253 | |
| 0.104 | 0.02 | 0.104 | Acetylcholine M2 receptor antagonist | 0.084 0.027 CID_3085253 0.061 0.044 CID_154699655 | ||
| 0.094 | 0.011 | 0.144 | NMDA receptor subunit 3B antagonist | 0.104 0.01 CID_3085253 0.144 0.007 CID_154699655 | CID_154699655 | |
| 0.093 | 0.012 | 0.098 | Dopamine D2 agonist | 0.084 0.013 CID_3085253 0.098 0.011 CID_154699655 | CID_154699655 | |
| 0.089 | 0.011 | 0.089 | Histamine agonist | 0.076 0.016 CID_3085253 | ||
| 0.14 | 0.063 | 0.14 | Toll-Like receptor antagonist | 0.118 0.088 CID_3085253 | ||
| 0.094 | 0.018 | 0.094 | Calcium channel T-type blocker | 0.08 0.022 CID_3085253 | ||
| 0.09 | 0.014 | 0.09 | Dopamine transporter inhibitor | 0.046 0.036 CID_3085253 0.054 0.029 CID_154699655 | ||
| 0.118 | 0.043 | 0.126 | Protein kinase C mu inhibitor | 0.126 0.038 CID_3085253 0.093 0.064 CID_154699655 | CID_3085253 | |
| 0.088 | 0.013 | 0.092 | MDM2 inhibitor | 0.092 0.01 CID_3085253 0.069 0.042 CID_154699655 | CID_3085253 | |
| 0.123 | 0.05 | 0.209 | GABA C receptor antagonist | 0.209 0.011 CID_3085253 0.108 0.067 CID_154699655 | CID_3085253 | |
| 0.103 | 0.031 | 0.122 | Myeloperoxidase inhibitor | 0.122 0.019 CID_3085253 0.101 0.034 CID_154699655 | CID_3085253 | |
| 0.077 | 0.005 | 0.077 | Endothelial nitric-oxide synthase inhibitor | 0.07 0.005 CID_3085253 | ||
| 0.1 | 0.029 | 0.1 | Cannabinoid receptor antagonist | 0.082 0.038 CID_3085253 | ||
| 0.102 | 0.033 | 0.108 | Telomerase inhibitor | 0.108 0.03 CID_3085253 0.081 0.044 CID_154699655 | CID_3085253 | |
| 0.195 | 0.126 | 0.268 | Interleukin agonist | 0.268 0.066 CID_3085253 | CID_3085253 | |
| 0.094 | 0.025 | 0.122 | Protein kinase C alpha inhibitor | 0.122 0.015 CID_3085253 0.076 0.037 CID_154699655 | CID_3085253 | |
| 0.103 | 0.035 | 0.103 | Acetylcholine nicotinic agonist | |||
| 0.079 | 0.012 | 0.079 | Thromboxane synthase inhibitor | 0.067 0.02 CID_3085253 0.07 0.017 CID_154699655 | ||
| 0.11 | 0.045 | 0.135 | Electrolyte absorption antagonist | 0.135 0.026 CID_3085253 | CID_3085253 | |
| 0.078 | 0.013 | 0.078 | 5 Hydroxytryptamine 1B agonist | 0.059 0.028 CID_3085253 0.055 0.033 CID_154699655 | ||
| 0.07 | 0.005 | 0.115 | Dopamine autoreceptor agonist | 0.028 0.014 CID_3085253 0.115 0.004 CID_154699655 | CID_154699655 | |
| 0.09 | 0.026 | 0.09 | Vanilloid 4 agonist | 0.072 0.06 CID_154699655 | ||
| 0.072 | 0.009 | 0.072 | CC chemokine 4 receptor antagonist | 0.054 0.022 CID_3085253 | ||
| 0.091 | 0.03 | 0.091 | Cannabinoid receptor agonist | 0.082 0.034 CID_3085253 | ||
| 0.139 | 0.078 | 0.15 | Ca2+-transporting ATPase inhibitor | 0.15 0.043 CID_3085253 0.132 0.108 CID_154699655 | CID_3085253 | |
| 0.12 | 0.06 | 0.176 | Transcription factor STAT6 inhibitor | 0.176 0.011 CID_3085253 0.117 0.064 CID_154699655 | CID_3085253 | |
| 0.098 | 0.038 | 0.148 | Adrenaline agonist | 0.148 0.015 CID_154699655 | CID_154699655 | |
| 0.074 | 0.015 | 0.074 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.077 | 0.02 | 0.077 | Potassium channel (Ca-activated) blocker | 0.074 0.023 CID_3085253 | ||
| 0.078 | 0.021 | 0.078 | Sigma receptor antagonist | 0.063 0.026 CID_3085253 0.075 0.022 CID_154699655 | ||
| 0.071 | 0.014 | 0.101 | NMDA receptor subunit 3A antagonist | 0.074 0.013 CID_3085253 0.101 0.008 CID_154699655 | CID_154699655 | |
| 0.064 | 0.007 | 0.064 | Sigma 2 receptor antagonist | 0.055 0.009 CID_3085253 0.036 0.014 CID_154699655 | ||
| 0.08 | 0.025 | 0.211 | NMDA 2C receptor antagonist | 0.211 0.005 CID_3085253 0.073 0.03 CID_154699655 | CID_3085253 | |
| 0.065 | 0.01 | 0.065 | Benzodiazepine antagonist | 0.052 0.023 CID_3085253 | ||
| 0.081 | 0.026 | 0.081 | Cannabinoid CB1 receptor antagonist | 0.069 0.035 CID_3085253 | ||
| 0.075 | 0.02 | 0.081 | Calcium channel P-type blocker | 0.081 0.014 CID_3085253 | CID_3085253 | |
| 0.095 | 0.041 | 0.112 | Hematopoietic | 0.112 0.026 CID_3085253 0.085 0.06 CID_154699655 | CID_3085253 | |
| 0.075 | 0.022 | 0.111 | Corticotropin releasing factor 2 receptor antagonist | 0.111 0.005 CID_3085253 | CID_3085253 | |
| 0.095 | 0.042 | 0.095 | Inducible nitric-oxide synthase inhibitor | 0.095 0.042 CID_3085253 | ||
| 0.213 | 0.162 | 0.247 | Antithrombotic | 0.238 0.136 CID_3085253 0.247 0.129 CID_154699655 | CID_154699655 | |
| 0.154 | 0.105 | 0.219 | Amyloid beta aggregation inhibitor | 0.177 0.09 CID_3085253 0.219 0.068 CID_154699655 | CID_154699655 | |
| 0.097 | 0.048 | 0.158 | Protein kinase A inhibitor | 0.158 0.022 CID_3085253 | CID_3085253 | |
| 0.064 | 0.017 | 0.074 | Dopamine D5 antagonist | 0.067 0.016 CID_3085253 0.074 0.014 CID_154699655 | CID_154699655 | |
| 0.067 | 0.021 | 0.083 | Chemokine receptor agonist | 0.083 0.007 CID_3085253 | CID_3085253 | |
| 0.075 | 0.028 | 0.075 | Acetylcholine M3 receptor antagonist | 0.058 0.043 CID_3085253 0.063 0.038 CID_154699655 | ||
| 0.069 | 0.024 | 0.069 | Cannabinoid CB2 receptor antagonist | 0.045 0.04 CID_3085253 0.056 0.033 CID_154699655 | ||
| 0.076 | 0.031 | 0.098 | NMDA receptor agonist | 0.098 0.02 CID_3085253 0.059 0.049 CID_154699655 | CID_3085253 | |
| 0.104 | 0.061 | 0.105 | Factor V inhibitor | 0.105 0.059 CID_3085253 0.093 0.089 CID_154699655 | CID_3085253 | |
| 0.089 | 0.046 | 0.089 | Acetylcholine nicotinic antagonist | 0.075 0.061 CID_3085253 | ||
| 0.114 | 0.071 | 0.114 | Calcium channel N-type blocker | |||
| 0.123 | 0.081 | 0.123 | Sodium channel (voltage-gated) blocker | 0.117 0.087 CID_3085253 | ||
| 0.056 | 0.016 | 0.06 | Dopamine D3 agonist | 0.06 0.014 CID_3085253 0.048 0.021 CID_154699655 | CID_3085253 | |
| 0.085 | 0.045 | 0.115 | Interferon agonist | 0.115 0.019 CID_3085253 | CID_3085253 | |
| 0.051 | 0.013 | 0.092 | 5 Hydroxytryptamine 2B agonist | 0.092 0.004 CID_3085253 0.04 0.024 CID_154699655 | CID_3085253 | |
| 0.079 | 0.041 | 0.079 | Benzodiazepine agonist | 0.076 0.044 CID_3085253 | ||
| 0.064 | 0.027 | 0.091 | Protein kinase C epsilon inhibitor | 0.091 0.015 CID_3085253 0.047 0.045 CID_154699655 | CID_3085253 | |
| 0.136 | 0.1 | 0.286 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.286 0.037 CID_3085253 | CID_3085253 | |
| 0.049 | 0.015 | 0.061 | Nociceptin (N/OFQ) receptor antagonist | 0.061 0.01 CID_3085253 0.032 0.027 CID_154699655 | CID_3085253 | |
| 0.064 | 0.031 | 0.064 | 5 Hydroxytryptamine 1 agonist | |||
| 0.081 | 0.049 | 0.083 | Nicotinic alpha4beta2 receptor antagonist | 0.083 0.046 CID_3085253 | CID_3085253 | |
| 0.112 | 0.08 | 0.148 | Aldehyde dehydrogenase inhibitor | 0.148 0.048 CID_3085253 0.125 0.066 CID_154699655 | CID_3085253 | |
| 0.064 | 0.031 | 0.064 | Acetylcholine muscarinic agonist | |||
| 0.198 | 0.166 | 0.2 | Cholesterol antagonist | 0.2 0.165 CID_3085253 0.186 0.178 CID_154699655 | CID_3085253 | |
| 0.064 | 0.032 | 0.078 | Beta 1 adrenoreceptor antagonist | 0.078 0.02 CID_154699655 | CID_154699655 | |
| 0.094 | 0.062 | 0.107 | Prolactin inhibitor | 0.102 0.054 CID_3085253 0.107 0.049 CID_154699655 | CID_154699655 | |
| 0.08 | 0.049 | 0.085 | Viral attachment inhibitor | 0.085 0.039 CID_3085253 | CID_3085253 | |
| 0.115 | 0.084 | 0.115 | DNA repair enzyme inhibitor | 0.108 0.103 CID_3085253 0.107 0.103 CID_154699655 | ||
| 0.107 | 0.076 | 0.134 | Photosensitizer | 0.134 0.042 CID_3085253 0.102 0.085 CID_154699655 | CID_3085253 | |
| 0.059 | 0.03 | 0.059 | Melanin-concentrating hormone receptor 1 antagonist | |||
| 0.044 | 0.016 | 0.044 | Delayed rectifier potassium channel blocker | |||
| 0.07 | 0.042 | 0.074 | 5 Hydroxytryptamine 3A antagonist | 0.074 0.037 CID_3085253 | CID_3085253 | |
| 0.121 | 0.094 | 0.121 | Sphingosine 1-phosphate receptor 2 antagonist | 0.117 0.103 CID_3085253 | ||
| 0.108 | 0.08 | 0.108 | Sphingosine 1-phosphate receptor 2 agonist | 0.107 0.083 CID_3085253 | ||
| 0.147 | 0.122 | 0.147 | P-glycoprotein inhibitor | 0.146 0.123 CID_154699655 | ||
| 0.115 | 0.091 | 0.115 | Sodium channel blocker | 0.107 0.102 CID_3085253 | ||
| 0.037 | 0.014 | 0.04 | Sigma 1 receptor antagonist | 0.027 0.018 CID_3085253 0.04 0.013 CID_154699655 | CID_154699655 | |
| 0.046 | 0.024 | 0.092 | Antidiuretic hormone antagonist | 0.092 0.014 CID_3085253 | CID_3085253 | |
| 0.039 | 0.017 | 0.047 | CXC chemokine receptor agonist | 0.047 0.005 CID_3085253 | CID_3085253 | |
| 0.173 | 0.151 | 0.37 | Superoxide dismutase inhibitor | 0.37 0.032 CID_3085253 | CID_3085253 | |
| 0.045 | 0.025 | 0.045 | Nerve growth factor antagonist | 0.041 0.032 CID_3085253 | ||
| 0.198 | 0.178 | 0.198 | Vasodilator, peripheral | |||
| 0.027 | 0.008 | 0.027 | Histamine H4 receptor agonist | 0.024 0.009 CID_3085253 | ||
| 0.035 | 0.017 | 0.035 | Protein kinase C beta I inhibitor | 0.032 0.03 CID_3085253 0.033 0.023 CID_154699655 | ||
| 0.044 | 0.027 | 0.048 | Heme oxygenase inhibitor | 0.048 0.016 CID_3085253 | CID_3085253 | |
| 0.063 | 0.046 | 0.088 | Interferon inducer | 0.088 0.018 CID_3085253 | CID_3085253 | |
| 0.041 | 0.025 | 0.074 | GABA uptake inhibitor | 0.074 0.006 CID_3085253 | CID_3085253 | |
| 0.035 | 0.018 | 0.035 | Vanilloid 4 antagonist | |||
| 0.097 | 0.081 | 0.129 | GABA receptor agonist | 0.129 0.049 CID_3085253 | CID_3085253 | |
| 0.054 | 0.038 | 0.054 | Cannabinoid CB2 receptor agonist | |||
| 0.044 | 0.029 | 0.044 | Histamine H2 receptor agonist | |||
| 0.043 | 0.028 | 0.043 | Alpha 1L adrenoreceptor agonist | 0.041 0.036 CID_3085253 | ||
| 0.026 | 0.012 | 0.026 | 5 Hydroxytryptamine 4 agonist | 0.026 0.012 CID_3085253 | ||
| 0.046 | 0.032 | 0.046 | 5 Hydroxytryptamine 1A agonist | |||
| 0.046 | 0.033 | 0.046 | Baculoviral IAP repeat-containing protein inhibitor | |||
| 0.036 | 0.024 | 0.043 | p53 inhibitor | 0.043 0.018 CID_3085253 | CID_3085253 | |
| 0.061 | 0.049 | 0.065 | Prolactin release inhibitor | 0.065 0.033 CID_3085253 0.061 0.049 CID_154699655 | CID_3085253 | |
| 0.019 | 0.007 | 0.031 | CXC chemokine 4 receptor agonist | 0.031 0.003 CID_3085253 | CID_3085253 | |
| 0.044 | 0.033 | 0.062 | 5 Hydroxytryptamine 2C agonist | 0.062 0.019 CID_3085253 0.043 0.033 CID_154699655 | CID_3085253 | |
| 0.042 | 0.031 | 0.042 | Acetylcholine M1 receptor agonist | |||
| 0.035 | 0.024 | 0.035 | Adenosine uptake inhibitor | 0.033 0.031 CID_3085253 | ||
| 0.029 | 0.019 | 0.034 | Thrombin receptor antagonist | 0.034 0.014 CID_3085253 | CID_3085253 | |
| 0.165 | 0.155 | 0.166 | Calpain inhibitor | 0.166 0.155 CID_3085253 | CID_3085253 | |
| 0.034 | 0.024 | 0.034 | RNA-directed RNA polymerase inhibitor | 0.032 0.028 CID_154699655 | ||
| 0.077 | 0.068 | 0.077 | Caspase 7 inhibitor | |||
| 0.035 | 0.025 | 0.035 | Ceramide glucosyltransferase inhibitor | |||
| 0.111 | 0.102 | 0.121 | Histone deacetylase SIRT1 inhibitor | 0.121 0.09 CID_3085253 | CID_3085253 | |
| 0.245 | 0.236 | 0.355 | 5 Hydroxytryptamine release inhibitor | 0.355 0.111 CID_3085253 | CID_3085253 | |
| 0.061 | 0.052 | 0.061 | Kallikrein 7 inhibitor | |||
| 0.082 | 0.074 | 0.115 | MAO B inhibitor | 0.115 0.053 CID_3085253 0.09 0.066 CID_154699655 | CID_3085253 | |
| 0.075 | 0.067 | 0.076 | Opioid kappa receptor antagonist | 0.076 0.065 CID_154699655 | CID_154699655 | |
| 0.041 | 0.033 | 0.041 | Histamine H3 receptor antagonist | |||
| 0.035 | 0.028 | 0.147 | Kinesin antagonist | 0.147 0.005 CID_3085253 | CID_3085253 | |
| 0.035 | 0.028 | 0.147 | Kinesin-like protein 1 inhibitor | 0.147 0.005 CID_3085253 | CID_3085253 | |
| 0.032 | 0.024 | 0.032 | Protein kinase C beta II inhibitor | 0.03 0.028 CID_3085253 | ||
| 0.081 | 0.075 | 0.092 | ATPase (Vacuolar H+) inhibitor | 0.092 0.052 CID_154699655 | CID_154699655 | |
| 0.054 | 0.047 | 0.059 | Pregnane X receptor antagonist | 0.059 0.034 CID_3085253 | CID_3085253 | |
| 0.027 | 0.02 | 0.027 | LFA antagonist | 0.026 0.023 CID_3085253 | ||
| 0.051 | 0.045 | 0.051 | Nicotinic neuronal receptor agonist | |||
| 0.036 | 0.03 | 0.036 | Alpha 1d adrenoreceptor agonist | 0.035 0.033 CID_3085253 | ||
| 0.101 | 0.095 | 0.176 | Glutamate receptor antagonist | 0.176 0.035 CID_3085253 0.101 0.096 CID_154699655 | CID_3085253 | |
| 0.026 | 0.021 | 0.026 | Myristoyl transferase inhibitor | 0.026 0.021 CID_3085253 | ||
| 0.033 | 0.027 | 0.033 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.06 | 0.054 | 0.06 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.047 | 0.041 | 0.05 | Beta 2 adrenoreceptor antagonist | 0.05 0.037 CID_154699655 | CID_154699655 | |
| 0.085 | 0.08 | 0.14 | Creatine kinase inhibitor | 0.14 0.028 CID_3085253 0.134 0.032 CID_154699655 | CID_3085253 | |
| 0.03 | 0.025 | 0.045 | Vasopressin 1 antagonist | 0.045 0.016 CID_3085253 | CID_3085253 | |
| 0.087 | 0.082 | 0.108 | Urease inhibitor | 0.108 0.057 CID_3085253 0.093 0.076 CID_154699655 | CID_3085253 | |
| 0.06 | 0.056 | 0.078 | Beta adrenoreceptor antagonist | 0.078 0.029 CID_154699655 | CID_154699655 | |
| 0.058 | 0.055 | 0.058 | Histone deacetylase SIRT3 inhibitor | 0.058 0.055 CID_3085253 | ||
| 0.036 | 0.034 | 0.036 | Histone deacetylase 8 inhibitor | |||
| 0.058 | 0.056 | 0.058 | Neuronal nicotinic receptor antagonist | |||
| 0.04 | 0.037 | 0.04 | Phosphorylase inhibitor | |||
| 0.062 | 0.061 | 0.062 | Amidase inhibitor | |||
| 0.036 | 0.035 | 0.059 | AMPA 4 receptor antagonist | 0.059 0.011 CID_3085253 | CID_3085253 | |
| 0.058 | 0.057 | 0.072 | Acetylcholine M5 receptor agonist | 0.072 0.041 CID_3085253 | CID_3085253 | |
| 0.025 | 0.024 | 0.049 | AMPA 3 receptor antagonist | 0.049 0.009 CID_3085253 | CID_3085253 | |
| 0.011 | 0.01 | 0.011 | Integrin beta2 antagonist | |||
| 0.046 | 0.046 | 0.046 | Sodium/calcium exchanger inhibitor | 0.046 0.044 CID_3085253 | CID_3085253 | |
| 0.055 | 0.057 | 0.078 | 5 Hydroxytryptamine 3 agonist | 0.078 0.028 CID_3085253 | CID_3085253 | |
| 0.121 | 0.124 | 0.15 | Sphingosine 1-phosphate receptor 5 antagonist | 0.15 0.061 CID_3085253 | CID_3085253 | |
| 0.026 | 0.031 | 0.041 | Sirtuin 2 inhibitor | 0.041 0.017 CID_3085253 | CID_3085253 | |
| 0.136 | 0.141 | 0.173 | Succinate dehydrogenase inhibitor | 0.173 0.077 CID_3085253 | CID_3085253 | |
| 0.054 | 0.06 | 0.056 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.056 0.052 CID_154699655 | CID_154699655 | |
| 0.176 | 0.183 | 0.204 | Hypoxia-inducible factor 1 alpha inhibitor | 0.204 0.147 CID_154699655 | CID_154699655 | |
| 0.105 | 0.113 | 0.179 | Protein kinase C nu inhibitor | 0.179 0.056 CID_3085253 | CID_3085253 | |
| 0.031 | 0.038 | 0.051 | Somatostatin 4 agonist | 0.051 0.015 CID_3085253 | CID_3085253 | |
| 0.04 | 0.048 | 0.049 | Parathyroid hormone antagonist | 0.049 0.024 CID_3085253 | CID_3085253 | |
| 0.025 | 0.034 | 0.043 | Vasopressin 2 antagonist | 0.043 0.017 CID_3085253 | CID_3085253 | |
| 0.02 | 0.029 | 0.031 | Vasopressin 1A antagonist | 0.031 0.018 CID_3085253 | CID_3085253 | |
| 0.022 | 0.034 | 0.026 | Antidiuretic hormone agonist | 0.026 0.022 CID_3085253 | CID_3085253 | |
| 0.056 | 0.069 | 0.063 | Beta 2 adrenoreceptor agonist | 0.063 0.037 CID_154699655 | CID_154699655 | |
| 0.014 | 0.027 | 0.018 | Complement factor D inhibitor | 0.018 0.012 CID_3085253 | CID_3085253 | |
| 0.087 | 0.104 | 0.096 | Histone deacetylase class III inhibitor | 0.096 0.094 CID_3085253 | CID_3085253 | |
| 0.03 | 0.048 | 0.066 | Dopamine D5 agonist | 0.066 0.009 CID_3085253 0.037 0.032 CID_154699655 | CID_3085253 | |
| 0.169 | 0.189 | 0.295 | Transcription factor STAT inhibitor | 0.295 0.059 CID_3085253 | CID_3085253 | |
| 0.11 | 0.129 | 0.129 | Insulin secretagoues | 0.129 0.098 CID_3085253 | CID_3085253 | |
| 0.045 | 0.066 | 0.051 | Epithelial sodium channel blocker | 0.051 0.048 CID_3085253 | CID_3085253 | |
| 0.019 | 0.04 | 0.026 | Calcium-sensing receptor agonist | 0.026 0.018 CID_3085253 | CID_3085253 | |
| 0.035 | 0.056 | 0.042 | Farnesyltransferase inhibitor | 0.042 0.038 CID_3085253 | CID_3085253 | |
| 0.126 | 0.147 | 0.143 | Heat shock protein 70 antagonist | 0.143 0.064 CID_3085253 | CID_3085253 | |
| 0.049 | 0.071 | 0.062 | Potassium channel intermediate-conductance Ca-activated blocker | 0.062 0.038 CID_3085253 | CID_3085253 | |
| 0.014 | 0.037 | 0.04 | AMPA 1 receptor antagonist | 0.04 0.015 CID_3085253 | CID_3085253 | |
| 0.138 | 0.163 | 0.255 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.255 0.058 CID_3085253 | CID_3085253 | |
| 0.022 | 0.046 | 0.03 | 5 Hydroxytryptamine 6 agonist | 0.03 0.017 CID_3085253 | CID_3085253 | |
| 0.066 | 0.093 | 0.096 | Potassium channel (Ca-activated) activator | 0.096 0.059 CID_154699655 | CID_154699655 | |
| 0.09 | 0.119 | 0.148 | Cyclooxygenase 3 inhibitor | 0.148 0.05 CID_3085253 | CID_3085253 | |
| 0.023 | 0.054 | 0.033 | Melanocortin 1 antagonist | 0.033 0.032 CID_3085253 | CID_3085253 | |
| 0.056 | 0.087 | 0.077 | CYP2A6 inhibitor | 0.077 0.051 CID_3085253 | CID_3085253 | |
| 0.06 | 0.091 | 0.078 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.078 0.041 CID_3085253 | CID_3085253 | |
| 0.177 | 0.21 | 0.222 | Caspase 3 stimulant | 0.222 0.14 CID_154699655 | CID_154699655 | |
| 0.032 | 0.066 | 0.081 | GABA B receptor antagonist | 0.081 0.006 CID_3085253 | CID_3085253 | |
| 0.081 | 0.116 | 0.098 | MAP kinase 13 inhibitor | 0.098 0.085 CID_3085253 | CID_3085253 | |
| 0.028 | 0.065 | 0.045 | Neurokinin 2 agonist | 0.045 0.024 CID_3085253 | CID_3085253 | |
| 0.04 | 0.076 | 0.066 | NMDA receptor glycine site agonist | 0.066 0.04 CID_3085253 | CID_3085253 | |
| 0.05 | 0.09 | 0.068 | Potassium channel large-conductance Ca-activated activator | 0.068 0.047 CID_154699655 | CID_154699655 | |
| 0.09 | 0.131 | 0.111 | Cathepsin H inhibitor | 0.111 0.088 CID_3085253 | CID_3085253 | |
| 0.186 | 0.228 | 0.251 | 15-Lipoxygenase inhibitor | 0.208 0.205 CID_3085253 0.251 0.164 CID_154699655 | CID_154699655 | |
| 0.037 | 0.081 | 0.045 | Beta adrenoreceptor agonist | 0.045 0.033 CID_154699655 | CID_154699655 | |
| 0.12 | 0.166 | 0.139 | 3C-like protease (Human coronavirus) inhibitor | 0.139 0.122 CID_3085253 | CID_3085253 | |
| 0.063 | 0.109 | 0.105 | Protein kinase C delta inhibitor | 0.105 0.048 CID_3085253 | CID_3085253 | |
| 0.036 | 0.082 | 0.051 | Lysine-specific demethylase 1A inhibitor | 0.051 0.042 CID_3085253 | CID_3085253 | |
| 0.028 | 0.074 | 0.044 | Nicotinic receptor alpha3 subunit antagonist | 0.044 0.03 CID_3085253 | CID_3085253 | |
| 0.027 | 0.073 | 0.045 | AMPA receptor antagonist | 0.045 0.037 CID_3085253 | CID_3085253 | |
| 0.164 | 0.21 | 0.216 | Transcription factor NF kappa B inhibitor | 0.216 0.154 CID_154699655 | CID_154699655 | |
| 0.024 | 0.071 | 0.054 | Growth hormone release inhibitor | 0.054 0.019 CID_3085253 | CID_3085253 | |
| 0.066 | 0.116 | 0.09 | Interleukin 5 antagonist | 0.09 0.055 CID_3085253 | CID_3085253 | |
| 0.104 | 0.158 | 0.127 | Thiol protease inhibitor | 0.127 0.102 CID_3085253 | CID_3085253 | |
| 0.052 | 0.106 | 0.112 | GABA aminotransferase inhibitor | 0.112 0.02 CID_3085253 | CID_3085253 | |
| 0.063 | 0.118 | 0.096 | Alcohol dehydrogenase inhibitor | 0.096 0.057 CID_3085253 | CID_3085253 | |
| 0.152 | 0.208 | 0.231 | Transcription factor STAT3 inhibitor | 0.231 0.101 CID_3085253 | CID_3085253 | |
| 0.034 | 0.09 | 0.047 | Dopamine beta hydroxylase inhibitor | 0.047 0.039 CID_3085253 | CID_3085253 | |
| 0.059 | 0.116 | 0.101 | GABA B receptor agonist | 0.101 0.015 CID_3085253 | CID_3085253 | |
| 0.016 | 0.076 | 0.043 | Phosphoglycerate kinase inhibitor | 0.043 0.018 CID_3085253 | CID_3085253 | |
| 0.063 | 0.126 | 0.088 | NADH dehydrogenase inhibitor | 0.088 0.059 CID_3085253 | CID_3085253 | |
| 0.033 | 0.099 | 0.059 | NMDA 2B receptor antagonist | 0.059 0.032 CID_3085253 | CID_3085253 | |
| 0.035 | 0.103 | 0.053 | Protein kinase C iota inhibitor | 0.053 0.049 CID_3085253 | CID_3085253 | |
| 0.047 | 0.116 | 0.133 | Protein kinase B gamma inhibitor | 0.133 0.021 CID_3085253 | CID_3085253 | |
| 0.057 | 0.126 | 0.092 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.092 0.046 CID_3085253 | CID_3085253 | |
| 0.126 | 0.196 | 0.155 | Vasodilator | 0.155 0.149 CID_154699655 | CID_154699655 | |
| 0.064 | 0.136 | 0.105 | Topoisomerase II inhibitor | 0.105 0.081 CID_154699655 | CID_154699655 | |
| 0.035 | 0.111 | 0.056 | Botulinum neurotoxin type A inhibitor | 0.056 0.045 CID_3085253 | CID_3085253 | |
| 0.055 | 0.133 | 0.074 | Estrogen receptor alpha antagonist | 0.074 0.06 CID_154699655 | CID_154699655 | |
| 0.008 | 0.088 | 0.033 | Somatostatin 2 antagonist | 0.033 0.019 CID_3085253 | CID_3085253 | |
| 0.196 | 0.28 | 0.279 | Apoptosis agonist | 0.279 0.188 CID_154699655 | CID_154699655 | |
| 0.047 | 0.136 | 0.069 | Exportin-1 inhibitor | 0.069 0.045 CID_3085253 | CID_3085253 | |
| 0.101 | 0.191 | 0.137 | DNA methylase inhibitor | 0.137 0.13 CID_3085253 | CID_3085253 | |
| 0.109 | 0.203 | 0.188 | Immunostimulant | 0.188 0.128 CID_3085253 | CID_3085253 | |
| 0.068 | 0.162 | 0.113 | Ribosomal protein S6 kinase inhibitor | 0.113 0.099 CID_3085253 | CID_3085253 | |
| 0.057 | 0.153 | 0.091 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.091 0.065 CID_3085253 | CID_3085253 | |
| 0.013 | 0.11 | 0.037 | Somatostatin agonist | 0.037 0.018 CID_3085253 | CID_3085253 | |
| 0.047 | 0.144 | 0.117 | Glycine receptor agonist | 0.117 0.014 CID_3085253 | CID_3085253 | |
| 0.028 | 0.126 | 0.043 | Glutamate (mGluR group III) antagonist | 0.043 0.031 CID_3085253 | CID_3085253 | |
| 0.083 | 0.187 | 0.137 | Phospholipase A2 inhibitor | 0.137 0.09 CID_3085253 | CID_3085253 | |
| 0.013 | 0.12 | 0.045 | Vascular adhesion protein 1 inhibitor | 0.045 0.019 CID_3085253 | CID_3085253 | |
| 0.016 | 0.126 | 0.053 | Somatostatin 5 agonist | 0.053 0.011 CID_3085253 | CID_3085253 | |
| 0.055 | 0.167 | 0.092 | Cystathionine beta-synthase inhibitor | 0.092 0.087 CID_154699655 | CID_154699655 | |
| 0.025 | 0.143 | 0.04 | Glutamate (mGluR4) antagonist | 0.04 0.037 CID_3085253 | CID_3085253 | |
| 0.108 | 0.228 | 0.165 | Phospholipase C inhibitor | 0.165 0.08 CID_3085253 | CID_3085253 | |
| 0.157 | 0.279 | 0.307 | Interleukin 2 agonist | 0.307 0.069 CID_3085253 | CID_3085253 | |
| 0.052 | 0.174 | 0.179 | GABA C receptor agonist | 0.179 0.025 CID_3085253 | CID_3085253 | |
| 0.049 | 0.176 | 0.082 | Aminoacyl-tRNA synthetase inhibitor | 0.082 0.073 CID_3085253 | CID_3085253 | |
| 0.058 | 0.197 | 0.12 | Nav1.4 sodium channel blocker | 0.12 0.052 CID_3085253 | CID_3085253 | |
| 0.049 | 0.188 | 0.092 | Ferrochelatase inhibitor | 0.092 0.08 CID_3085253 | CID_3085253 | |
| 0.048 | 0.193 | 0.1 | Chelator | 0.1 0.078 CID_154699655 | CID_154699655 | |
| 0.082 | 0.229 | 0.238 | Growth hormone agonist | 0.238 0.046 CID_3085253 | CID_3085253 | |
| 0.14 | 0.297 | 0.224 | Apoptosis antagonist | 0.224 0.153 CID_154699655 | CID_154699655 | |
| 0.066 | 0.223 | 0.128 | Peroxidase inhibitor | 0.128 0.093 CID_3085253 | CID_3085253 | |
| 0.037 | 0.2 | 0.083 | Aminopeptidase B inhibitor | 0.083 0.079 CID_3085253 | CID_3085253 | |
| 0.06 | 0.223 | 0.121 | Estrogen antagonist | 0.121 0.054 CID_154699655 | CID_154699655 | |
| 0.078 | 0.246 | 0.236 | Interleukin antagonist | 0.236 0.067 CID_3085253 | CID_3085253 | |
| 0.096 | 0.266 | 0.143 | MAP kinase kinase 4 inhibitor | 0.143 0.076 CID_154699655 | CID_154699655 | |
| 0.063 | 0.238 | 0.154 | Aryl hydrocarbon receptor agonist | 0.154 0.133 CID_3085253 | CID_3085253 | |
| 0.041 | 0.216 | 0.084 | HIV-1 integrase (Overall Integration) inhibitor | 0.084 0.073 CID_3085253 | CID_3085253 | |
| 0.053 | 0.236 | 0.09 | Carbonic anhydrase XV inhibitor | 0.09 0.084 CID_3085253 | CID_3085253 | |
| 0.062 | 0.277 | 0.131 | Heat shock protein 90 antagonist | 0.131 0.096 CID_154699655 | CID_154699655 | |
| 0.01 | 0.226 | 0.038 | Somatostatin 1 antagonist | 0.038 0.027 CID_3085253 | CID_3085253 | |
| 0.09 | 0.326 | 0.185 | Death-associated protein kinase 2 inhibitor | 0.185 0.048 CID_3085253 | CID_3085253 | |
| 0.037 | 0.293 | 0.104 | Estrogen receptor beta antagonist | 0.104 0.057 CID_154699655 | CID_154699655 | |
| 0.09 | 0.391 | 0.192 | Immunomodulator | 0.192 0.174 CID_3085253 | CID_3085253 | |
| 0.029 | 0.377 | 0.132 | Thrombolytic | 0.132 0.097 CID_3085253 | CID_3085253 | |
| 0.023 | 0.386 | 0.08 | Somatostatin 1 agonist | 0.08 0.051 CID_3085253 | CID_3085253 | |
| 0.042 | 0.418 | 0.165 | Free radical scavenger | 0.165 0.128 CID_154699655 | CID_154699655 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |